Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
about
Enhanced beta-cell mass without increased proliferation following chronic mild glucose infusionVagal control of pancreatic ß-cell proliferation.Dopamine modulates insulin release and is involved in the survival of rat pancreatic beta cellsHypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists.Cecal infusion of butyrate increases intestinal cell proliferation in pigletsRethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits.
P2860
Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Systemic treatment with sympat ...... reactive levels in ob/ob mice.
@en
type
label
Systemic treatment with sympat ...... reactive levels in ob/ob mice.
@en
prefLabel
Systemic treatment with sympat ...... reactive levels in ob/ob mice.
@en
P2093
P356
P1433
P1476
Systemic treatment with sympat ...... reactive levels in ob/ob mice.
@en
P2093
P304
P356
10.1053/META.2001.26741
P577
2001-11-01T00:00:00Z